News
Health and Me on MSN14m
FDA Vaccination Chief Vinay Prasad Returns To Job Within Days After Quitting Under Pressure, Who Is He?Dr. Vinay Prasad, who resigned just two weeks ago as head of the Food and Drug Administration’s vaccines and gene therapy ...
Vinay Prasad, a former critic of U.S. COVID-19 policies, returns to the FDA's Center for Biologics Evaluation and Research after briefly leaving. His tenure drew criticism, notably over the handling ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
President Trump announced a trade deal with South Korea on Wednesday, putting 15 percent tariffs on South Korean goods, much ...
Vinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to ...
Stocktwits on MSN13d
Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About ElevidysShares of Sarepta Therapeutics Inc. (SRPT) traded 20% higher on Tuesday afternoon after the U.S. Food and Drug Administration ...
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Wall Street traders sent stocks lower in the run-up to the Federal Reserve decision, with concerns about high valuations ...
Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...
Sarepta Therapeutics has experienced a whirlwind week as the FDA unexpectedly reversed its recommendation to suspend shipments of Elevidys, the company's gene therapy for Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results